This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n6http://linked.opendata.cz/resource/drugbank/drug/DB07588/identifier/pubchem-substance/
n12http://linked.opendata.cz/resource/drugbank/drug/DB07588/identifier/drugbank/
n10http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n11http://linked.opendata.cz/resource/drugbank/drug/DB07588/identifier/chemspider/
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n7http://linked.opendata.cz/resource/drugbank/drug/DB07588/identifier/pdb/
n8http://linked.opendata.cz/resource/drugbank/drug/DB07588/identifier/pubchem-compound/

Statements

Subject Item
n2:DB07588
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n10:DB07588 n13:DB07588
dcterms:title
3,4-DI-1H-INDOL-3-YL-1H-PYRROLE-2,5-DICARBOXYLIC ACID
adms:identifier
n6:99444059 n7:CRR n8:11326613 n11:9501565 n12:DB07588
n3:IUPAC-Name
n4:271B52F0-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B52F6-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B52F5-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B52F2-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B52F3-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B52F4-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B52EE-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B52EC-363D-11E5-9242-09173F13E4C5 n4:271B52EF-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B52ED-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B52FC-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B52FD-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B52F7-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B52F8-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B52FA-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B52F9-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B52FB-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5301-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5303-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5304-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5300-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B52FF-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5302-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B52F1-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B52FE-363D-11E5-9242-09173F13E4C5